M
Moqing Liu
Researcher at Oregon Health & Science University
Publications - 9
Citations - 521
Moqing Liu is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Lapatinib & Cancer. The author has an hindex of 4, co-authored 6 publications receiving 448 citations.
Papers
More filters
Journal ArticleDOI
23 High Redshift Supernovae from the IfA Deep Survey: Doubling the SN Sample at z>0.7
Brian J. Barris,John L. Tonry,Stephane Blondin,Peter Challis,Ryan Chornock,Alejandro Clocchiatti,Alexei V. Filippenko,Peter M. Garnavich,Stephen T. Holland,Saurabh Jha,Robert P. Kirshner,Kevin Krisciunas,Bruno Leibundgut,Weidong Li,Thomas Matheson,Gajus Miknaitis,Adam G. Riess,Brian P. Schmidt,R. Chris Smith,Jesper Sollerman,Jason Spyromilio,Christopher W. Stubbs,Nicholas B. Suntzeff,Herve Aussel,K. C. Chambers,M. S. Connelley,David Donovan,J. P. Henry,Nick Kaiser,Moqing Liu,Eduardo L. Martín,R. J. Wainscoat +31 more
TL;DR: In this article, photometric and spectroscopic observations of 23 high redshift supernovae spanning a range of z=0.34-1.03, 9 of which are unambiguously classified as Type Ia are presented.
Journal ArticleDOI
Microenvironment-Mediated Mechanisms of Resistance to HER2 Inhibitors Differ between HER2+ Breast Cancer Subtypes
S. Watson,Mark A. Dane,Koei Chin,Zuzana Tatarova,Moqing Liu,Tiera Liby,Wallace Thompson,Rebecca Smith,Michel Nederlof,Elmar Bucher,David Kilburn,Matthew Whitman,Damir Sudar,Gordon B. Mills,Laura M. Heiser,Oliver Jonas,Joe W. Gray,James E. Korkola +17 more
TL;DR: Different mechanisms of resistance specific to each HER2+ subtype are suggested, including MET signaling for HER2E and HER2-HER3 heterodimerization for L-HER2+ cells.
Journal ArticleDOI
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease.
Rebecca Smith,Moqing Liu,Tiera Liby,Nora Bayani,Elmar Bucher,Kami E. Chiotti,Daniel S. Derrick,Anne Chauchereau,Laura M. Heiser,Joshi J. Alumkal,Joshi J. Alumkal,Heidi S. Feiler,Peter R. Carroll,James E. Korkola +13 more
TL;DR: This study reinforces the utility of large cell line panels for the study of cancer and identifies several cell lines that represent ideal models to study AR-null cells that have upregulated GR to sustain growth.
Proceedings ArticleDOI
Abstract S6-07: Detrimental effects of sequential compared to concurrent treatment of pertuzumab plus T-DM1 in HER2+ breast cancer cell lines
TL;DR: Initial screens showed that concurrent treatment of cells with pertuzumab plus T-DM1 gave significant synergistic interactions in 15/21 cell lines as measured by the median effect method, with combination indices less than 0.5 (and 95% upper confidence levels less than 1.0) for at least one drug concentration.
Journal ArticleDOI
A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses
Sean M. Gross,Mark A. Dane,Rebecca Smith,Kaylyn Devlin,Ian Mclean,Daniel S. Derrick,Caitlin E. Mills,Kartik Subramanian,Alexandra B. London,Denis Torre,John Erol Evangelista,Daniel J.B. Clarke,Zhuorui Xie,Cemal Erdem,Nicholas J. Lyons,Ted Natoli,Sarah Pessa,Xiaodong Lu,James Mullahoo,Jonathan Li,Miriam Adam,Brook T. Wassie,Moqing Liu,David Kilburn,Tiera Liby,Elmar Bucher,Crystal Sanchez-Aguila,Kenneth Daily,Larsson Omberg,Yunguan Wang,Connor A. Jacobson,Clarence Yapp,Mirra Chung,Dusica Vidovic,Yiling Lu,S. Schurer,Albert Lee,Ajay S. Pillai,Aravind Subramanian,Malvina Papanastasiou,Ernest Fraenkel,Heidi S. Feiler,Gordon B. Mills,Jake Jaffe,Avi Ma'ayan,Marc R. Birtwistle,Peter K. Sorger,James E. Korkola,Joe W. Gray,Laura M. Heiser +49 more
TL;DR: The LINCS Microenvironment (ME) perturbation dataset as discussed by the authors is a dataset that catalogs the transcriptional, proteomic, epigenomic and phenotypic responses of MCF10A mammary epithelial cells after exposure to the ligands EGF, HGF, OSM, IFNG, TGFB and BMP2.